was read the article
array:25 [ "pii" => "S1665268120302209" "issn" => "16652681" "doi" => "10.1016/j.aohep.2020.100295" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "100295" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Ann Hepatol. 2021;22C:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S1665268121000259" "issn" => "16652681" "doi" => "10.1016/j.aohep.2021.100326" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "100326" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Ann Hepatol. 2021;22C:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letters to the Editor</span>" "titulo" => "Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)" "tienePdf" => "en" "tieneTextoCompleto" => "en" "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ivan López-Mendez, Graciela Castro-Narro" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Ivan" "apellidos" => "López-Mendez" ] 1 => array:2 [ "nombre" => "Graciela" "apellidos" => "Castro-Narro" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121000259?idApp=UINPBA00004N" "url" => "/16652681/000000220000000C/v3_202107300613/S1665268121000259/v3_202107300613/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S166526812100034X" "issn" => "16652681" "doi" => "10.1016/j.aohep.2021.100335" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "100335" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Ann Hepatol. 2021;22C:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letters to the editor</span>" "titulo" => "Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measures" "tienePdf" => "en" "tieneTextoCompleto" => "en" "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Monica C. Preciado-Puga, Yeniley Ruiz-Noa, Juana R. Garcia-Ramirez, Benjamin Jordan-Perez, Serafin Garnelo-Cabañas, Maria L. Lazo de la Vega-Monroy, Karen I. Gutierrez-Aguirre, Lorena R. Ibarra-Reynoso" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Monica C." "apellidos" => "Preciado-Puga" ] 1 => array:2 [ "nombre" => "Yeniley" "apellidos" => "Ruiz-Noa" ] 2 => array:2 [ "nombre" => "Juana R." "apellidos" => "Garcia-Ramirez" ] 3 => array:2 [ "nombre" => "Benjamin" "apellidos" => "Jordan-Perez" ] 4 => array:2 [ "nombre" => "Serafin" "apellidos" => "Garnelo-Cabañas" ] 5 => array:2 [ "nombre" => "Maria L." "apellidos" => "Lazo de la Vega-Monroy" ] 6 => array:2 [ "nombre" => "Karen I." "apellidos" => "Gutierrez-Aguirre" ] 7 => array:2 [ "nombre" => "Lorena R." "apellidos" => "Ibarra-Reynoso" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S166526812100034X?idApp=UINPBA00004N" "url" => "/16652681/000000220000000C/v3_202107300613/S166526812100034X/v3_202107300613/en/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S1665268121000259" "issn" => "16652681" "doi" => "10.1016/j.aohep.2021.100326" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "100326" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Ann Hepatol. 2021;22C:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letters to the Editor</span>" "titulo" => "Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)" "tienePdf" => "en" "tieneTextoCompleto" => "en" "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ivan López-Mendez, Graciela Castro-Narro" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Ivan" "apellidos" => "López-Mendez" ] 1 => array:2 [ "nombre" => "Graciela" "apellidos" => "Castro-Narro" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121000259?idApp=UINPBA00004N" "url" => "/16652681/000000220000000C/v3_202107300613/S1665268121000259/v3_202107300613/en/main.assets" ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letters to the editor</span>" "titulo" => "Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Xiaofei Li" "autores" => array:1 [ 0 => array:4 [ "nombre" => "Xiaofei" "apellidos" => "Li" "email" => array:1 [ 0 => "icqwc46@163.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Infectious Diseases, YiWu Central Hospital, Zhejiang 322000, China" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">I read with great interest the research by Mendez et al. [<a class="elsevierStyleCrossRef" href="#bib0005">1</a>] mainly evaluated the association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19). The authors' great efforts provide evidence for assessing the prognosis of COVID-19 patients, but the following questions need to be considered.</p><p id="par0010" class="elsevierStylePara elsevierViewall">First, it should be emphasized that advanced liver fibrosis was defined as APRI > 1.0, NAFLD FS > 0.675 and/or FIB-4 > 3.25 in Mendez’s study, and the final result exhibited that steatosis and significant liver fibrosis was not associated with adverse outcomes. In contrast, a study based on COVID-19 patients defined advanced liver fibrosis as FIB-4 ≥ 2.67, and the results presented that liver fibrosis was associated with poor prognosis in COVID-19 patients [<a class="elsevierStyleCrossRef" href="#bib0010">2</a>]. The above description indicates that different definitions of liver fibrosis based on FIB-4 will lead to different outcomes, and might be misunderstood by clinicians, which will ultimately be detrimental to improving the prognosis of COVID-19 patients. In my opinion, it is extremely important to describe the theoretical basis of liver fibrosis grouping and provide evidence from previous studies, which might help to reduce confounding bias.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Second, the results of this study indicated that elevated glucose levels were associated with higher risk of ICU admission (OR = 3.58, 1.05 to 12.2, P = 0.041) (Table 3). However, we are curious that this conclusion is for diabetes patients? Or for non-diabetes patients? Obviously, 15.5% of the participants included in this study had type 2 diabetes. Therefore, it is necessary to conduct subgroup analysis [<a class="elsevierStyleCrossRef" href="#bib0015">3</a>] according to diabetes in order to explore the association between elevated glucose levels and ICU admission risk.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Third, obesity is prevalent worldwide nowadays, with an incidence rate of 40% [<a class="elsevierStyleCrossRef" href="#bib0020">4</a>,<a class="elsevierStyleCrossRef" href="#bib0025">5</a>,<a class="elsevierStyleCrossRef" href="#bib0030">6</a>]. In addition, obesity has been shown to be an independent risk factor for a range of diseases, including COVID-19 patients [<a class="elsevierStyleCrossRef" href="#bib0035">7</a>]. A meta-analysis of nine studies revealed that obesity was associated with the severity of COVID-19 and was associated with poor prognosis [<a class="elsevierStyleCrossRef" href="#bib0040">8</a>]. However, the results of Mendez’s study indicated that obesity is not associated with poor prognosis in COVID-19 patients, which is contrary to previous results. Additionally, this conclusion is even easy to cause clinicians to pay less attention to obese patients. In my opinion, insufficient statistical power may explain why obesity is not associated with poor prognosis in COVID-19 patients.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Declaration of funding interests</span><p id="par0025" class="elsevierStylePara elsevierViewall">None.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Conflict of interest</span><p id="par0030" class="elsevierStylePara elsevierViewall">The authors have no conflict of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Declaration of funding interests" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Conflict of interest" ] 2 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2020-10-29" "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:8 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "[1]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Lopez-Mendez" 1 => "J. Aquino-Matus" 2 => "S.M. Gall" 3 => "J.D. Prieto-Nava" 4 => "E. Juarez-Hernandez" 5 => "M. Uribe" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.aohep.2020.09.015" "Revista" => array:2 [ "tituloSerie" => "Annals of Hepatology" "fecha" => "2020" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "[2]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Elevation of liver fibrosis index FIB-4 is associated with poor clinical outcomes in patients with COVID-19" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Ibáñez-Samaniego" 1 => "F. Bighelli" 2 => "C. Usón" 3 => "C. Caravaca" 4 => "C.F. Carrillo" 5 => "M. Romero" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/infdis/jiaa355" "Revista" => array:7 [ "tituloSerie" => "The Journal of infectious diseases" "fecha" => "2020" "volumen" => "222" "numero" => "5" "paginaInicial" => "726" "paginaFinal" => "733" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32563190" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "[3]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "ST Lanza" 1 => "BL Rhoades" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11121-011-0201-1" "Revista" => array:7 [ "tituloSerie" => "Prevention Science" "fecha" => "2013" "volumen" => "14" "numero" => "2" "paginaInicial" => "157" "paginaFinal" => "168" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21318625" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "[4]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of adult overweight and obesity in 20 European countries, 2014" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Marques" 1 => "M. Peralta" 2 => "A. Naia" 3 => "N. Loureiro" 4 => "M.G. de Matos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurpub/ckx143" "Revista" => array:7 [ "tituloSerie" => "The European Journal of Public Health" "fecha" => "2018" "volumen" => "28" "numero" => "2" "paginaInicial" => "295" "paginaFinal" => "300" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29036436" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "[5]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C.M. Hales" 1 => "C.D. Fryar" 2 => "M.D. Carroll" 3 => "D.S. Freedman" 4 => "C.L. Ogden" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2018.3060" "Revista" => array:7 [ "tituloSerie" => "Jama" "fecha" => "2018" "volumen" => "319" "numero" => "16" "paginaInicial" => "1723" "paginaFinal" => "1725" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29570750" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "[6]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Differences in obesity prevalence by demographics and urbanization in US children and adolescents, 2013-2016" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "C.L. Ogden" 1 => "C.D. Fryar" 2 => "C.M. Hales" 3 => "M.D. Carroll" 4 => "Y. Aoki" 5 => "D.S. Freedman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2018.5158" "Revista" => array:7 [ "tituloSerie" => "Jama" "fecha" => "2018" "volumen" => "319" "numero" => "23" "paginaInicial" => "2410" "paginaFinal" => "2418" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29922826" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "[7]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Obesity and COVID-19 severity in a designated hospital in Shenzhen" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Q. Cai" 1 => "F. Chen" 2 => "T. Wang" 3 => "F. Luo" 4 => "X. Liu" 5 => "Q. Wu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc20-0576" "Revista" => array:7 [ "tituloSerie" => "China. Diabetes care" "fecha" => "2020" "volumen" => "43" "numero" => "7" "paginaInicial" => "1392" "paginaFinal" => "1398" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32409502" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "[8]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Obesity aggravates COVID‐19: a systematic review and meta‐analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Yang" 1 => "J. Hu" 2 => "C. Zhu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jmv.26237" "Revista" => array:2 [ "tituloSerie" => "Journal of medical virology" "fecha" => "2020" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/000000220000000C/v3_202107300613/S1665268120302209/v3_202107300613/en/main.assets" "Apartado" => array:4 [ "identificador" => "82754" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/000000220000000C/v3_202107300613/S1665268120302209/v3_202107300613/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268120302209?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 1 | 0 | 1 |
2024 October | 9 | 4 | 13 |
2024 September | 17 | 3 | 20 |
2024 August | 8 | 7 | 15 |
2024 July | 18 | 4 | 22 |
2024 June | 11 | 3 | 14 |
2024 May | 14 | 2 | 16 |
2024 April | 14 | 2 | 16 |
2024 March | 25 | 8 | 33 |
2024 February | 14 | 10 | 24 |
2024 January | 9 | 2 | 11 |
2023 December | 14 | 7 | 21 |
2023 November | 13 | 3 | 16 |
2023 October | 16 | 4 | 20 |
2023 September | 9 | 2 | 11 |
2023 August | 14 | 2 | 16 |
2023 July | 5 | 5 | 10 |
2023 June | 16 | 1 | 17 |
2023 May | 32 | 5 | 37 |
2023 April | 38 | 2 | 40 |
2023 March | 14 | 2 | 16 |
2023 February | 16 | 0 | 16 |
2023 January | 12 | 2 | 14 |
2022 December | 9 | 3 | 12 |
2022 November | 17 | 9 | 26 |
2022 October | 15 | 6 | 21 |
2022 September | 12 | 11 | 23 |
2022 August | 16 | 5 | 21 |
2022 July | 14 | 4 | 18 |
2022 June | 15 | 10 | 25 |
2022 May | 15 | 4 | 19 |
2022 April | 17 | 4 | 21 |
2022 March | 43 | 6 | 49 |
2022 February | 39 | 13 | 52 |
2022 January | 57 | 12 | 69 |
2021 December | 27 | 8 | 35 |
2021 November | 17 | 7 | 24 |
2021 October | 17 | 13 | 30 |
2021 September | 25 | 9 | 34 |
2021 August | 14 | 5 | 19 |
2021 July | 5 | 7 | 12 |
2021 June | 14 | 7 | 21 |
2021 May | 11 | 12 | 23 |
2021 April | 0 | 23 | 23 |
2021 March | 0 | 2 | 2 |
2021 February | 0 | 0 | 0 |